"RNA, Antisense" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
RNA molecules which hybridize to complementary sequences in either RNA or DNA altering the function of the latter. Endogenous antisense RNAs function as regulators of gene expression by a variety of mechanisms. Synthetic antisense RNAs are used to effect the functioning of specific genes for investigative or therapeutic purposes.
| Descriptor ID |
D016372
|
| MeSH Number(s) |
D13.150.650 D13.444.600.150.760 D13.444.735.150 D27.720.470.530.600.150.760
|
| Concept/Terms |
RNA, Antisense- RNA, Antisense
- Antisense RNA
- Anti-Sense RNA
- Anti Sense RNA
- RNA, Anti-Sense
|
Below are MeSH descriptors whose meaning is more general than "RNA, Antisense".
Below are MeSH descriptors whose meaning is more specific than "RNA, Antisense".
This graph shows the total number of publications written about "RNA, Antisense" by people in this website by year, and whether "RNA, Antisense" was a major or minor topic of these publications.
![]()
To see the data from this visualization as text,
click here.
Below are the most recent publications written about "RNA, Antisense" by people in Profiles.
-
Xie J, Ameres SL, Friedline R, Hung JH, Zhang Y, Xie Q, Zhong L, Su Q, He R, Li M, Li H, Mu X, Zhang H, Broderick JA, Kim JK, Weng Z, Flotte TR, Zamore PD, Gao G. Long-term, efficient inhibition of microRNA function in mice using rAAV vectors. Nat Methods. 2012 Mar 04; 9(4):403-9.
-
Shrimal S, Bhattacharya S, Bhattacharya A. Serum-dependent selective expression of EhTMKB1-9, a member of Entamoeba histolytica B1 family of transmembrane kinases. PLoS Pathog. 2010 Jun 03; 6(6):e1000929.
-
Nelson EJ, Tunsj? HS, Fidopiastis PM, S?rum H, Ruby EG. A novel lux operon in the cryptically bioluminescent fish pathogen Vibrio salmonicida is associated with virulence. Appl Environ Microbiol. 2007 Mar; 73(6):1825-33.